Assessment of safety and efficacy of lamotrigine over the course of 1-year observation in Japanese patients with bipolar disorder: post-marketing surveillance study report [Corrigendum]
Terao T, Ishida A, Kimura T, Yoshida M, Hara T. Neuropsychiatr Dis Treat. 2017;13:1441–1448.
On page 1443, Results section, Patient disposition subheading, Figure S1, ‘Excluded from HAM-D analysis setC 69’ should have been ‘Excluded from HAM-D analysis setC 269’.
Read the original article
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.